SA Pharmaceutical Journal - Volume 81, Issue 8, 2014
Volume 81, Issue 8, 2014
Author Lorraine OsmanSource: SA Pharmaceutical Journal 81 (2014)More Less
As you know, I spend an inordinate amount of my time (actually it's your time as I work for you) going to meetings. Some are routine: What's going on with X,Y and Z? Has there been any progress? What's the next step? Who's going to do the work? Some are boring. Invariably, the answers to those questions are: "Nothing", "No", "Who knows?" and "You are".
Author Johann KrugerSource: SA Pharmaceutical Journal 81 (2014)More Less
As I write this column, I am still trying to recover from jet lag after a very informative International Pharmaceutical Federation (FIP) conference held in Thailand, and more specifically, Bangkok. Many of you have been there, and would acknowledge that the food and the heat is a challenge. I was not one of the lucky ones who could enjoy cooling down in the ocean at Phuket or Pataya! Instead, we embarked upon daily train rides and spent the whole day in conference halls and discussions! That aside, it was once more time to benchmark pharmacy in South Africa against that of the world, and to show the world what South Africa is capable of offering in terms of new developments in our profession.
Report on the 75th International Pharmaceutical Federation World Congress of Pharmacy and Pharmaceutical Sciences, Bangkok, Thailand : PSSA perspectivesAuthor Mariet EksteenSource: SA Pharmaceutical Journal 81, pp 8 –9 (2014)More Less
What is it that makes the International Pharmaceutical Federation (FIP) the prestigious organisation that it is, representing more than three million pharmacists and pharmaceutical scientist worldwide? Who are the volunteers who dedicate their time and resources to build this organisation and support its initiatives and activities? How did it reach its 102nd year of existence, despite obstacles in the past? There is only one word which describes the contribution to all of these successes, and that is "differences", i.e. the different countries, nationalities, cultures, projects, contributions, opinions, suggestions and efforts.
Author Andy GraySource: SA Pharmaceutical Journal 81, pp 9 –10 (2014)More Less
The International Pharmaceutical Federation (FIP) Congress was held in Bangkok, Thailand, from 31 August to 4 September 2014. A number of elections were conducted. The overall structure of the FIP and its governance and leadership bodies can be confusing to new members, or to members of organisations that have recently joined the FIP. The FIP represents over three million practitioners and scientists from around the world and has a complex membership structure. There are individual members, member organisations (in two categories: primarily scientific organisations and organisations that predominantly represent pharmacists), observer organisations and academic institutional members.
Source: SA Pharmaceutical Journal 81, pp 14 –20 (2014)More Less
The red eye is the most common ocular complaint in patients seeking medical assistance at primary healthcare level. The differential diagnosis of the red eye varies from relatively innocuous and trivial conditions to those that are more devastating and potentially blinding. The purpose of this article is to help identify certain key clinical features of the discussed conditions, to help avoid pitfalls in diagnosis and to convey appropriate treatment modalities.
Author Lynn LambertSource: SA Pharmaceutical Journal 81, pp 24 –27 (2014)More Less
Cancer in South Africa is an emerging health problem, with breast cancer being a leading cancer in women. The medical treatment of breast cancer was solely reliant on cytotoxic chemotherapy for many years. A greater understanding of the underlying biology of breast cancer has resulted in the identification of a number of molecular targets and the development of novel therapeutic agents. Thus, treatment has evolved over the past decade into a more target-directed approach with the use of biological drugs. The three currently available biological drugs registered in South Africa for use in breast cancer include trastuzumab (Herceptin®), bevacizumab (Avastin®) and lapatinib (Tykerb®). This article briefly discusses their role in targeting breast cancer.
Source: SA Pharmaceutical Journal 81, pp 28 –31 (2014)More Less
The provision of palliative care in sub-Saharan Africa is a concern. A limited number of well resourced palliative care settings are available. Patient-level outcome measures are necessary to monitor and improve practice and patient care. This paper focuses on the use of the African Palliative Care Association (APCA) African Palliative Outcome Scale (POS) and pain scales used in clinical practice.
Source: SA Pharmaceutical Journal 81, pp 32 –36 (2014)More Less
The Academy of Pharmaceutical Sciences takes pleasure in sharing postgraduate students' success. The titles of the research projects provide insight into the scope and nature of pharmaceutical research taking place in the country. Unfortunately, only the main supervisor of each research project is listed owing to space limitations.
The Academy congratulates all of the graduates and wishes them well in their future careers.
Source: SA Pharmaceutical Journal 81 (2014)More Less
Profmed is the largest restricted medical scheme in South Africa uniquely designed for graduate professionals. Having its roots firmly planted since 1959 by the Professional Provident Society (PPS), it is one of the longest established medical schemes in South Africa. As the private health sector evolved over the decades, the implementation of the Medical Schemes Act in 1998 prescribed that all medical schemes are governed as separate entities, effectively unbundling Profmed from PPS. However, even as separate entities, Profmed continues to share a healthy and mutually beneficial relationship with PPS.